InsidersTradesSigma
Follow the 北陆药业 share price and the full insider trade history of the company, a listed equity based in China. Shares are listed on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 北陆药业 has published 7 public disclosures. Market capitalisation: €4.5bn. The latest transaction was reported on 3 June 2025 (Sale). Among the most active insiders: 宗利. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
7 of 7 declarations
北陆药业 es una empresa que opera en el sector de la salud y farmacéutico, cotiza en el mercado XSHE. Se centra en la investigación, desarrollo y producción de medicamentos innovadores.